United States · FDA National Drug Code directory
LAMOTRIGINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13668-695_1b3ee868-07fa-4918-a4e4-4a4730d19485
- Product NDC
- 13668-695
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- LAMOTRIGINE
- Labeler
- Torrent Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260108
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-695-01) · 13668-695-01
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-695-30) · 13668-695-30
- 30 BLISTER PACK in 1 CARTON (13668-695-72) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (13668-695-71) · 13668-695-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →